XML 28 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)
3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Stock Option [Member]
Jun. 30, 2013
Stock Option [Member]
Jun. 30, 2014
Stock Option [Member]
Jun. 30, 2013
Stock Option [Member]
Jun. 30, 2014
Equity Appreciation Rights Plan [Member]
Stock Appreciation Rights S A R S [Member]
Jun. 30, 2013
Equity Appreciation Rights Plan [Member]
Stock Appreciation Rights S A R S [Member]
Jun. 30, 2014
Equity Appreciation Rights Plan [Member]
Stock Appreciation Rights S A R S [Member]
Jun. 30, 2013
Equity Appreciation Rights Plan [Member]
Stock Appreciation Rights S A R S [Member]
Dec. 31, 2013
Equity Appreciation Rights Plan [Member]
Stock Appreciation Rights S A R S [Member]
Nov. 30, 2010
Equity Appreciation Rights Plan [Member]
Stock Appreciation Rights S A R S [Member]
Maximum [Member]
Options                            
Balance at the beginning of the period(in shares)             216,000              
Granted (in shares)         0 0 0 0            
Expired or forfeited (in shares)             (20,000)              
Balance at the end of the period (in shares)         196,000   196,000              
Exercisable at the end of the period (in shares)         172,918   172,918              
Weighted-Average Exercise Price Per Share                            
Outstanding at the beginning of the period (in dollars per share)             $ 6.46              
Expired or forfeited (in dollars per share)             $ 7.46              
Outstanding at the end of the period (in dollars per share)         $ 6.36   $ 6.36              
Exercisable at the end of the period (in dollars per share)         $ 6.70   $ 6.70              
Weighted-Average Remaining Contractual Term                            
Outstanding at the end of the period             3 years 5 months 1 day              
Exercisable at the end of the period             2 years 8 months 12 days              
Aggregate Intrinsic Value                            
Outstanding at the end of the period         $ 39,055   $ 39,055              
Exercisable at the end of the period         13,020   13,020              
Additional disclosures                            
Weighted-average fair value of options granted (in dollars per share)             $ 1.65              
Compensation expense         7,482 1,720 14,963 5,501 38,000 23,000 49,092 18,695    
Unrecognized compensation related to unvested awards         32,000   32,000              
Weighted-average period over which unrecognized compensation costs expected to be recognized             1 year 5 months 5 days              
Equity Appreciation Rights Plan                            
Number of common shares authorized                           750,000
Vesting period from the base date                     3 years      
Redemption cash payment period                     90 days      
Shares granted (in units)                     750,000      
Accrued compensation                 161,000   161,000   81,000  
Accrued compensation included in other accrued liabilities                 39,000   39,000   29,000  
Accrued compensation included in Other Long-Term Liabilities                 $ 122,000   $ 122,000   $ 52,000  
Awards exercised (in shares)         0 0 0 0            
Granted (in shares)         0 0 0 0            
Shares outstanding (in units)                 650,000   650,000      
Net Income Per Common Share                            
Options outstanding included in computation of per share amounts (in shares) 26,750 0 26,750 0                    
Outstanding options included computation of dilutive per-share amounts as effect of all outstanding stock-based awards were antidilutive   189,250   169,250                    
Reconciliation of basic and diluted share amounts                            
Basic weighted average common shares outstanding 2,742,992 2,742,992 2,742,992 2,742,992                    
Diluted weighted average common shares outstanding 2,746,856 2,742,992 2,747,357 2,742,992